Kardiovaskuläre Risikoevaluation in der Behandlung des Hodgkin-Lymphoms – auf dem Weg zur individualisierten Planung?
- Published in:
- 2023
- By:
- Publication type:
- Book Review
Works matching IS 01797158 AND DT 2023 AND VI 199 AND IP 3
Results: 12
1
2
SBRT von primären Nierenzellkarzinomen – Langzeitergebnisse der IROCK-Datenbank.
- Published in:
- 2023
- By:
- Publication type:
- Book Review
3
Verlängerung des Gesamtüberlebens durch die Impfung von autologen tumorlysatbeladenen dendritischen Zellen (DCVax-L) bei Patienten mit neu diagnostiziertem und rezidivierendem Glioblastom.
- Published in:
- 2023
- By:
- Publication type:
- Book Review
4
Chemoradiotherapy for untreated Masaoka–Koga stage IVB thymic carcinoma: a single-center retrospective study.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 313, doi. 10.1007/s00066-022-02042-w
- By:
- Publication type:
- Article
5
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 278, doi. 10.1007/s00066-022-02040-y
- By:
- Publication type:
- Article
6
Physical and nonphysical effects of weekly music therapy intervention on the condition of radiooncology patients.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 268, doi. 10.1007/s00066-022-02033-x
- By:
- Publication type:
- Article
7
Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 322, doi. 10.1007/s00066-022-02025-x
- By:
- Publication type:
- Article
8
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 304, doi. 10.1007/s00066-022-02023-z
- By:
- Publication type:
- Article
9
Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 293, doi. 10.1007/s00066-022-02022-0
- By:
- Publication type:
- Article
10
Traditional risk factors and nodal yield—still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 284, doi. 10.1007/s00066-022-02017-x
- By:
- Publication type:
- Article
11
Palliative care on the radiation oncology ward—improvements in clinical care through interdisciplinary ward rounds.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 251, doi. 10.1007/s00066-022-01989-0
- By:
- Publication type:
- Article
12
The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 3, p. 258, doi. 10.1007/s00066-022-01976-5
- By:
- Publication type:
- Article